GRCE — Grace Therapeutics, Inc.

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates GRCE Bearish with a Setup Score of 53, net conviction 46, actionability 62. How the Setup Score works →

Total Setup Score53
Directional BiasBearish
Net Conviction46
Actionability62 (in range)

Key signals behind this score

About Grace Therapeutics, Inc.

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T); and GTX-101, a topical bio adhesive film-form… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$2.18
Market Cap$45.0M
Float15.6M
Shares Outstanding21.0M
P/E (Forward)2.17
Price/Sales (TTM)197.75
vs. Analyst Target+178.0% to analyst PT
Dividend RateNone
Analyst Target Price$6.06 (2 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2021 $309,318 -$31.1M $189,378 -$15.5M
2022 N/A -$12.3M N/A -$19.2M
2023 N/A -$57.4M -$124,000 -$24.5M
2024 N/A -$17.4M -$11,000 -$15.4M
2025 N/A -$13.6M -$7,000 -$23.7M
2026 N/A -$7.8M -$6,999 -$11.1M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Sep 2025 N/A -$1.3M
Dec 2025 N/A -$3.2M
Mar 2026 N/A -$1.2M
Jun 2026 N/A -$15.8M

Ownership & Float

Insider Ownership18.2%
Institutional Ownership31.4%
Short Float10.2%
% of All Funds Holding0.39%
Number of Funds Holding34

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$2.27Near-term / short-term trend
Weekly40-Week SMA$3.11Medium-term trend
Weekly80-Week SMA$3.01Cyclical trend (business cycle)
Weekly200-Week SMA$2.97Secular trend (multi-year)
Monthly10-Month SMA$3.05Near-term monthly trend
Monthly20-Month SMA$2.98Medium-term monthly trend
Monthly40-Month SMA$2.93Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$4.80 resistance 5.40x 3 months ago

Historical Earnings Reactions (57 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.23% 0.00% 29.82% 25.93% -13.19%
1 Day -0.91% -0.86% 35.09% 22.45% -15.15%
1 Week 0.18% -1.94% 42.11% 59.54% -33.64%
2 Weeks -1.39% -4.33% 41.07% 52.38% -32.12%
1 Month -4.79% -4.33% 37.50% 61.70% -75.00%

Next earnings: November 1, 2026 (68 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan4.7%57.1%14
Feb-1.8%35.7%14
Mar-2.5%46.7%15
Apr-6.1%26.7%15
May1.1%66.7%15
Jun-0.5%46.7%15
Jul13.0%46.7%15
Aug-15.4%7.1%14
Sep7.4%42.9%14
Oct-9.5%21.4%14
Nov-1.7%57.1%14
Dec5.3%71.4%14

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.11% 36.6% 686
Tuesday -0.19% 36.0% 751
Wednesday 0.53% 39.5% 749
Thursday -0.03% 39.1% 736
Friday -0.01% 38.6% 733

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 31.4%

Insider Transactions — Smart Summary

Total insider ownership: 18.2%

12-Month Insider Activity Summary

Total Filings1
Net Value+N/A
Net Shares Change11,608
% of Float0.1%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Opaleye Management Inc. +$24,206.162 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-08-18 Opaleye Management Inc. +$24,206.162 Transaction at $2.09, now +4.5%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Grace Therapeutics, Inc. (GRCE) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for GRCE on Trend Edge →